Resten-NG: Began Phase I testing

(Research news, B13)

AVI Biopharma Inc. (AVII), Portland, Ore.

Read the full 90 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE